Three plaintiffs suing Boston Scientific in Philadelphia over allegedly defective pelvic mesh have agreed to litigate their cases elsewhere in light of the latest jurisdictional pronouncement from the U.S. Supreme Court.
Last month, Boston Scientific had asked the court to remove any cases pending against it in the Philadelphia Court of Common Pleas, citing the Supreme Court’s recent game-changing decisions in Bristol-Myers Squibb v. Superior Court of California and BNSF Railway v. Tyrrell. But, according to a lead attorney in the litigation, the parties have agreed to litigate the cases in either Massachusetts, where Boston Scientific has its principal place of business, or Delaware.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
